glp 1 receptor agonist heart failure Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology GLP-1 Pathophysiology for Heart Failure

DOI: 10.1093/jn/132.4.636 Vermeulen, R

About 40.4% of participants lost 25% or more of their starting body weight

New retatrutide data raise the ceiling for what next-generation metabolic drugs may eventually achieve, but investigational results should not be confused with an available treatment plan

As the accumulation of melanin contributes to dark spots and uneven skin tone, undergoing this treatment can result in a lighter complexion

The GLP-1 that is often used as shorthand for the entire drug family Ozempic is officially indicated only for Type 2 diabetes, though it remains prescribed off-label even after its now-numerous sibling drugs entered the market